10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,834,064 | -6.4% | 92,947 | +26.7% | 0.48% | -14.2% |
| Q2 2023 | $4,097,874 | -0.1% | 73,386 | -0.1% | 0.56% | +1.4% |
| Q1 2023 | $4,100,286 | -0.2% | 73,495 | +166.5% | 0.56% | +77.6% |
| Q4 2021 | $4,107,000 | -21.2% | 27,573 | -23.0% | 0.31% | -16.3% |
| Q3 2021 | $5,212,000 | -7.9% | 35,800 | +23.9% | 0.37% | 0.0% |
| Q2 2021 | $5,659,000 | -13.6% | 28,900 | -20.2% | 0.37% | -20.6% |
| Q1 2021 | $6,552,000 | +9.1% | 36,200 | -14.6% | 0.47% | +16.0% |
| Q4 2020 | $6,004,000 | -26.5% | 42,401 | -35.3% | 0.41% | -24.7% |
| Q3 2020 | $8,169,000 | +13.1% | 65,522 | -19.0% | 0.54% | +9.6% |
| Q2 2020 | $7,225,000 | – | 80,900 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |